Skip to content

Clinical trials

Recruiting Ovarian Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Status: Recruiting Country / region: Taiwan Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20211
20225
20232
20244
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Daiichi Sankyo4
Merck Sharp & Dohme LLC3
Chang Gung Memorial Hospital2
AbbVie1
Academia Sinica, Taiwan1
DualityBio Inc.1
Eli Lilly and Company1
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc1
Kaohsiung Medical University Chung-Ho Memorial Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms23
Endometrial Neoplasms6
Fallopian Tube Neoplasms6
Stomach Neoplasms4
Uterine Cervical Neoplasms4
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Melanoma3
Squamous Cell Carcinoma of Head and Neck3
Biliary Tract Neoplasms2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.